TMCnet News
Research and Markets: Contact Dermatitis Therapeutics Pipeline Insights 2015Research and Markets (http://www.researchandmarkets.com/research/2thbcl/contact) has announced the addition of the "Contact Dermatitis-Pipeline Insights" report to their offering. Contact Dermatitis Pipeline Insights provides the in-depth analysis of the pipeline assets across the Contact Dermatitis landscape. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Contact Dermatitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. Contact Dermatitis Pipeline Insights Report covers the Cotact Dermatitis pipeline molecules at various stages of development like Pre-registration phases, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Contact Dermatitis related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Contact Dermatitis. Scope - The report provides a Contact Dermatitis Landscape across the globe. - The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information. - Coverage of the Contact Dermatitis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type. - The report reviews key players involved in the therapeutics development for Contact Dermatitis and also provide company profiling. - Pipeline products coverage based on various stages of development from NDA filings to discovery. - Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type. For more information visit http://www.researchandmarkets.com/research/2thbcl/contact
View source version on businesswire.com: http://www.businesswire.com/news/home/20150804006825/en/ |
